1 China Biotechnology Co., Ltd.
Since the establishment of People's Republic of China (PRC), the biological products enterprises affiliated to Zhongsheng Co., Ltd. have been undertaking the production and supply of biological products for preventing, controlling and eliminating infectious diseases in China. It has strong industrialization ability and production bases in six major cities. Among the 4 1 vaccine varieties that can be produced in China, Zhongsheng Co., Ltd. can produce 35 kinds with an annual output of more than 700 million doses.
Beijing Tiantan biological products co., ltd.
The company is one of the research and production bases of biological products and a listed company under the jurisdiction of China Biotechnology Group, a central enterprise. The company is mainly engaged in the research and development, production and sales of biological products such as vaccines, blood preparations and diagnostic supplies.
The leading products include more than 20 varieties such as recombinant yeast hepatitis B vaccine, live rubella vaccine, polio vaccine, inactivated Japanese encephalitis vaccine, combined leprosy vaccine (MR) and various diagnostic reagents. The main products account for more than 50% of the domestic market share.
3. Kexing Holding Biotechnology Co., Ltd..
Beijing Kexing Biological Products Co., Ltd. is a biological high-tech enterprise jointly funded by Kexing Holdings (Hong Kong) Co., Ltd. and Weiming Biomedical Co., Ltd., which was incorporated in Beijing Zhongguancun National Independent Innovation Demonstration Zone on 200 1. At present, Beijing Kexing is listed on the Nasdaq Global Select Market through Kexing Holding Biotechnology Co., Ltd., and it is the only American vaccine enterprise listed in North China.
4. Hualan Bioengineering Co., Ltd..
Hualan Bioengineering Co., Ltd. Hualan Bioengineering Co., Ltd. (formerly known as Hualan Bioengineering Co., Ltd.) was established in 1992. It is a national key high-tech enterprise engaged in the research and development and production of blood products, and passed the GMP certification of blood products industry for the first time in 1998.
5. China Biological Products Co., Ltd.
China Biotechnology Group Co., Ltd. was established in 1989 (formerly known as China Biological Products Corporation, renamed in August 2003, hereinafter referred to as Zhongsheng Group), and was originally an important state-owned backbone enterprise managed by the State Council State-owned Assets Supervision and Administration Commission.